VERU INC. SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
VERU INC. (VERU) had SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount of $2.40 million as of 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesBalance · last filed 2019-08-08
- 2019-06-30: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $2.40M.
- 2019-03-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $1.60M.
- 2012-09-30: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $49.81K.
- 2011-09-30: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $75.95K.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount |
|---|---|
| 2019-06-30 | $2.40M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.60M 10-Q · filed 2019-05-15 |
| 2012-09-30 | $49.81K 10-K · filed 2012-12-04 |
| 2011-09-30 | $75.95K 10-K · filed 2012-12-04 |
| 2010-09-30 | $15.46K 10-K · filed 2012-12-04 |
| 2009-09-30 | $95.57K 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |